Expression of Phosphomimetic OSTM1-T328E/S329D Variant Partially Restores Bone Resorption Defect in LRRK1-Deficient...

Area of Science:

• Cell Biology
• Bone Biology
• Molecular Biology

Background:

• LRRK1 (Leucine-rich repeat kinase 1) is crucial for osteoclast-mediated bone resorption; its deficiency causes osteopetrosis.
• The precise mechanisms of LRRK1 in regulating osteoclast activity are not fully understood.
• OSTM1 phosphorylation at T328/S329 was previously found to be impaired in LRRK1-deficient osteoclasts.

Purpose of the Study:

• To investigate the role of OSTM1 phosphorylation in LRRK1-mediated osteoclast function.
• To determine if restoring OSTM1 phosphorylation can rescue bone resorption defects in LRRK1-deficient models.

Main Methods:

• Expression of phosphomimetic and dephosphomimetic OSTM1 variants in LRRK1-null osteoclasts in vitro.
• Generation and analysis of Ostm1-T328E/S329D knock-in mice crossed with Lrrk1-deficient mice.
• Assessment of osteoclast resorptive activity, bone formation, and skeletal architecture.

Main Results:

• Overexpression of phosphomimetic OSTM1 partially restored resorptive activity in LRRK1-deficient osteoclasts.
• Ostm1-T328E/S329D knock-in mice showed normal skeletal development.
• In Lrrk1-deficient mice, OSTM1-T328E/S329D expression partially improved osteoclast activity, bone formation, and trabecular architecture.

Conclusions:

• OSTM1 phosphorylation is a key component in the LRRK1-dependent regulation of osteoclast function.
• The LRRK1-OSTM1 pathway is a critical regulator of bone resorption.
• OSTM1 phosphorylation represents a potential therapeutic target for metabolic bone diseases.